Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 8, 2020

View Archived Issues

New regeneration factor for muscle cells

Escape reports phase I data on oral S1P5 receptor agonist ESB-1609

Novel potent NAMPT inhibitor reduces tumor growth in mouse model of TNBC

SM-09419 shows promising antitumor activity in preclinical models of hematologic malignancies

New humanized transgenic mouse model of FNAIT

Apellis announces positive topline data from phase III PEGASUS study of pegcetacoplan in PNH

SX-682 blocks key immunosuppressive tumor cells

Galapagos synthesizes SIK1, SIK2 and SIK3 inhibitors

Canakkale Onsekiz Mart Ueniversitesi divulges EEF2K inhibitors

Georgia State University discloses compounds for bacterial infections

Scripps Research Institute presents myosin-2 ATPase activity inhibitors

Nanchang University identifies antibodies for enterovirus 71 infections

Cobra genome may yield new antivenoms, venom-based drugs

New CD7-negative T cells presented as potential treatment for CD7-positive cancer

CStone begins phase III study of CS-1001 for advanced esophageal squamous cell carcinoma

Takeda opens recruitment in phase II study of TAK-079 for generalized myasthenia gravis

Cerevel starts phase III study of tavapadon in early Parkinson's disease

Dosing begins in phase IIa trial of avasopasem manganese to reduce radiation-induced esophagitis

CureVac reports interim phase I data on prophylactic mRNA-based rabies vaccine CV-7202

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...